Answers are grounded in this paper and cite their sources.
The translation of microbial biotechnology from laboratory research to commercial application remains a persistent challenge, despite decades of effort. A key yet often neglected issue is the misalignment between microbial host selection, product properties, and process constraints at the early stages, which often limits scalability. Here, we propose Microbe-Specific and Product-Specific Strategies (MPSS) as a conceptual framework to rationalize host-product pairing based on intrinsic microbial traits and product specifications. By incorporating Applied Microbial Population Biology (AMPB), the framework extends this rationale to the strain level, emphasizing application-oriented strain selection and engineering from the outset of a project. Together, MPSS and AMPB offer a structured approach to align early-stage laboratory research with the practical requirements of industrial biomanufacturing, enabling the development of biotechnological solutions with significant societal and economic impact.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: